The government has increased the budget for the promotion of bulk drug parks to Rs 1,000 crore for FY25, a significant increase from the previous year. The total outlay for the development of the pharmaceutical industry for FY25 has also been increased to Rs 1,300 crore. Additionally, the budget for the promotion of medical device parks has been raised to Rs 150 crore for FY25. The allocation for assistance to medical device clusters for common facilities has also been increased to Rs 40 crore.
The growth of the pharma sector has been nothing short of tremendous. With this momentum and with the support of public and private partnerships, India has all the capabilities to reach $120-$130 billion by 2030
The Indian Institute of Foreign Trade, which conducted the study, found that pharmaceuticals is one of the sectors where the dependence on Chinese imports is so high that the industry can’t function without these products.
An interview with Dinesh Thakur and Prashant Reddy about India’s drug manufacturing industry and recent cases of India-made drugs leading to the deaths of children in Uzbekistan and Gambia.
Wirtschaftsbeziehungen: Patentstreit belastet die neue Partnerschaft zwischen Europa und Indien msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.